Cellino Raises $80m Series A To Transform Stem Cell Therapy Manufacturing
Leaps By Bayer Is Lead Investor
Executive Summary
The Cambridge, MA start-up aims to ‘democratize’ therapies based on induced pluripotent stem cells by developing an automated manufacturing system.